In:
PLOS Biology, Public Library of Science (PLoS), Vol. 21, No. 5 ( 2023-5-8), p. e3002110-
Abstract:
Toxoplasma gondii is a widespread apicomplexan parasite that can cause severe disease in its human hosts. The ability of T . gondii and other apicomplexan parasites to invade into, egress from, and move between cells of the hosts they infect is critical to parasite virulence and disease progression. An unusual and highly conserved parasite myosin motor (TgMyoA) plays a central role in T . gondii motility. The goal of this work was to determine whether the parasite’s motility and lytic cycle can be disrupted through pharmacological inhibition of TgMyoA, as an approach to altering disease progression in vivo. To this end, we first sought to identify inhibitors of TgMyoA by screening a collection of 50,000 structurally diverse small molecules for inhibitors of the recombinant motor’s actin-activated ATPase activity. The top hit to emerge from the screen, KNX-002, inhibited TgMyoA with little to no effect on any of the vertebrate myosins tested. KNX-002 was also active against parasites, inhibiting parasite motility and growth in culture in a dose-dependent manner. We used chemical mutagenesis, selection in KNX-002, and targeted sequencing to identify a mutation in TgMyoA (T130A) that renders the recombinant motor less sensitive to compound. Compared to wild-type parasites, parasites expressing the T130A mutation showed reduced sensitivity to KNX-002 in motility and growth assays, confirming TgMyoA as a biologically relevant target of KNX-002. Finally, we present evidence that KNX-002 can slow disease progression in mice infected with wild-type parasites, but not parasites expressing the resistance-conferring TgMyoA T130A mutation. Taken together, these data demonstrate the specificity of KNX-002 for TgMyoA, both in vitro and in vivo, and validate TgMyoA as a druggable target in infections with T . gondii . Since TgMyoA is essential for virulence, conserved in apicomplexan parasites, and distinctly different from the myosins found in humans, pharmacological inhibition of MyoA offers a promising new approach to treating the devastating diseases caused by T . gondii and other apicomplexan parasites.
Type of Medium:
Online Resource
ISSN:
1545-7885
DOI:
10.1371/journal.pbio.3002110
DOI:
10.1371/journal.pbio.3002110.g001
DOI:
10.1371/journal.pbio.3002110.g002
DOI:
10.1371/journal.pbio.3002110.g003
DOI:
10.1371/journal.pbio.3002110.g004
DOI:
10.1371/journal.pbio.3002110.g005
DOI:
10.1371/journal.pbio.3002110.g006
DOI:
10.1371/journal.pbio.3002110.g007
DOI:
10.1371/journal.pbio.3002110.g008
DOI:
10.1371/journal.pbio.3002110.g009
DOI:
10.1371/journal.pbio.3002110.s001
DOI:
10.1371/journal.pbio.3002110.s002
DOI:
10.1371/journal.pbio.3002110.s003
DOI:
10.1371/journal.pbio.3002110.s004
DOI:
10.1371/journal.pbio.3002110.s005
DOI:
10.1371/journal.pbio.3002110.s006
DOI:
10.1371/journal.pbio.3002110.s007
DOI:
10.1371/journal.pbio.3002110.s008
DOI:
10.1371/journal.pbio.3002110.s009
DOI:
10.1371/journal.pbio.3002110.s010
DOI:
10.1371/journal.pbio.3002110.s011
DOI:
10.1371/journal.pbio.3002110.s012
DOI:
10.1371/journal.pbio.3002110.s013
DOI:
10.1371/journal.pbio.3002110.s014
DOI:
10.1371/journal.pbio.3002110.s015
DOI:
10.1371/journal.pbio.3002110.s016
DOI:
10.1371/journal.pbio.3002110.s017
DOI:
10.1371/journal.pbio.3002110.s018
DOI:
10.1371/journal.pbio.3002110.s019
DOI:
10.1371/journal.pbio.3002110.s020
DOI:
10.1371/journal.pbio.3002110.s021
DOI:
10.1371/journal.pbio.3002110.s022
DOI:
10.1371/journal.pbio.3002110.s023
DOI:
10.1371/journal.pbio.3002110.s024
DOI:
10.1371/journal.pbio.3002110.s025
DOI:
10.1371/journal.pbio.3002110.s026
DOI:
10.1371/journal.pbio.3002110.s027
DOI:
10.1371/journal.pbio.3002110.s028
DOI:
10.1371/journal.pbio.3002110.s029
DOI:
10.1371/journal.pbio.3002110.s030
DOI:
10.1371/journal.pbio.3002110.s031
DOI:
10.1371/journal.pbio.3002110.s032
DOI:
10.1371/journal.pbio.3002110.s033
DOI:
10.1371/journal.pbio.3002110.s034
DOI:
10.1371/journal.pbio.3002110.s035
DOI:
10.1371/journal.pbio.3002110.s036
DOI:
10.1371/journal.pbio.3002110.s037
DOI:
10.1371/journal.pbio.3002110.s038
DOI:
10.1371/journal.pbio.3002110.s039
DOI:
10.1371/journal.pbio.3002110.s040
DOI:
10.1371/journal.pbio.3002110.s041
DOI:
10.1371/journal.pbio.3002110.s042
DOI:
10.1371/journal.pbio.3002110.s043
DOI:
10.1371/journal.pbio.3002110.r001
DOI:
10.1371/journal.pbio.3002110.r002
DOI:
10.1371/journal.pbio.3002110.r003
DOI:
10.1371/journal.pbio.3002110.r004
DOI:
10.1371/journal.pbio.3002110.r005
DOI:
10.1371/journal.pbio.3002110.r006
Language:
English
Publisher:
Public Library of Science (PLoS)
Publication Date:
2023
detail.hit.zdb_id:
2126773-X
Bookmarklink